Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,562.18 -58.38 (-0.09%) CMC Crypto 200
1,419.36 -9.21 (-0.64%)
Dassault Systèmes SE (DSYN.MX)
| Previous close | 700.13 |
| Open | 0.00 |
| Bid | 0.00 x 90000 |
| Ask | 0.00 x 0 |
| Day's range | 700.13 - 700.13 |
| 52-week range | 695.33 - 859.91 |
| Volume | |
| Avg. volume | 62 |
| Market cap | 917.954B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 46.96 |
| EPS (TTM) | 14.91 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 4.20 (0.60%) |
| Ex-dividend date | 28 May 2024 |
| 1y target est | N/A |
Business WireLexicon Pharmaceuticals Selects Medidata to Help Advance First Non-Opioid Drug for Neuropathic Pain in Over Two Decades
NEW YORK, May 29, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced today that it has been selected by Lexicon Pharmaceuticals, Inc. to help advance PROGRESS, a Phase 2b study of LX9211 in diabetic peripheral neuropathic pain (DPNP), with the potential for LX9211 to become the first new, non-opioid drug approved for neuropathic pain in over two decades. Medidata will enable Lexicon to accelerate patient enrollment
Business WireMedidata Selected by Worldwide Clinical Trials to Accelerate Trials and Transform Patient Experience
NEW YORK, May 14, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an expansion of its relationship with Worldwide Clinical Trials ("Worldwide"), a full-service global contract research organization (CRO). The agreement will facilitate data-driven decision-making across Worldwide’s entire clinical operations with the implementation of Medidata AI and enable Worldwide to support customers by reducing trial ti
- GlobeNewswire
Dassault Systèmes: JLR and Dassault Systèmes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs Worldwide
Press ReleaseVELIZY-VILLACOUBLAY, France — May 14, 2024 JLR and Dassault Systèmes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs Worldwide Five-year partnership marks the next phase of their long-standing collaboration to drive the automaker’s transformation for a good and responsible businessMore than 18,000 users globally will utilize virtual twins to increase the efficiency of vehicle engineering and digital manufacturing, save time, and reduce waste and cost
